Skip to content

Public FDA record

Z-2059-2018: RX Imola (RX4900) For Professional Use for the quantitative in vitro determination of various clinical c

Recall record Z-2059-2018 for Randox Laboratories. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2059-2018
Company in FDA record
Randox Laboratories
FDA record creation date
Jun 4, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Abnormal premature termination of the software could affect the use of the analyser when running patient samples. The impact being a delay in reporting test results.

Source facts

Action
All customers will be contacted directly by email and will be followed up with once every 2 weeks over a period of 6 weeks. Customers are advised to update the software in all analyzers. For further questions, please call 1 (866)472-6369.
Initiated
2018-05-04
Root cause
Under Investigation by firm
Terminated
2020-06-16
Distribution
US Distribution including Puerto Rico and the state of : West Virginia.
Recall number
Z-2059-2018
Recall status
Terminated
CDRH record ID
164051
FDA record created
2018-06-04
Recall event number
79968

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗